190 related articles for article (PubMed ID: 7887428)
1. Characterization of revertant muscle fibers in Duchenne muscular dystrophy, using exon-specific monoclonal antibodies against dystrophin.
Thanh LT; Nguyen TM; Helliwell TR; Morris GE
Am J Hum Genet; 1995 Mar; 56(3):725-31. PubMed ID: 7887428
[TBL] [Abstract][Full Text] [Related]
2. Frameshift deletions of exons 3-7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production.
Winnard AV; Mendell JR; Prior TW; Florence J; Burghes AH
Am J Hum Genet; 1995 Jan; 56(1):158-66. PubMed ID: 7825572
[TBL] [Abstract][Full Text] [Related]
3. Exon skipping and translation in patients with frameshift deletions in the dystrophin gene.
Sherratt TG; Vulliamy T; Dubowitz V; Sewry CA; Strong PN
Am J Hum Genet; 1993 Nov; 53(5):1007-15. PubMed ID: 8213828
[TBL] [Abstract][Full Text] [Related]
4. Characterization of genetic deletions in Becker muscular dystrophy using monoclonal antibodies against a deletion-prone region of dystrophin.
Le Thiet Thanh ; Nguyen Thi Man ; Hori S; Sewry CA; Dubowitz V; Morris GE
Am J Med Genet; 1995 Aug; 58(2):177-86. PubMed ID: 8533812
[TBL] [Abstract][Full Text] [Related]
5. Use of epitope libraries to identify exon-specific monoclonal antibodies for characterization of altered dystrophins in muscular dystrophy.
Nguyen TM; Morris GE
Am J Hum Genet; 1993 Jun; 52(6):1057-66. PubMed ID: 7684887
[TBL] [Abstract][Full Text] [Related]
6. Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy.
Winnard AV; Klein CJ; Coovert DD; Prior T; Papp A; Snyder P; Bulman DE; Ray PN; McAndrew P; King W
Hum Mol Genet; 1993 Jun; 2(6):737-44. PubMed ID: 8353493
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies against the muscle-specific N-terminus of dystrophin: characterization of dystrophin in a muscular dystrophy patient with a frameshift deletion of exons 3-7.
Le TT; Nguyen TM; Love DR; Helliwell TR; Davies KE; Morris GE
Am J Hum Genet; 1993 Jul; 53(1):131-9. PubMed ID: 8317478
[TBL] [Abstract][Full Text] [Related]
8. Somatic reversion/suppression in Duchenne muscular dystrophy (DMD): evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers.
Klein CJ; Coovert DD; Bulman DE; Ray PN; Mendell JR; Burghes AH
Am J Hum Genet; 1992 May; 50(5):950-9. PubMed ID: 1570844
[TBL] [Abstract][Full Text] [Related]
9. A truncated dystrophin lacking the C-terminal domains is localized at the muscle membrane.
Helliwell TR; Ellis JM; Mountford RC; Appleton RE; Morris GE
Am J Hum Genet; 1992 Mar; 50(3):508-14. PubMed ID: 1539591
[TBL] [Abstract][Full Text] [Related]
10. Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin Expression.
Lee JJA; Saito T; Duddy W; Takeda S; Yokota T
Methods Mol Biol; 2018; 1828():141-150. PubMed ID: 30171539
[TBL] [Abstract][Full Text] [Related]
11. Immunostaining of dystrophin and utrophin in skeletal muscle of dystrophinopathies.
Sahashi K; Ibi T; Suoh H; Nakao N; Tashiro M; Marui K; Arahata K; Sugita H
Intern Med; 1994 May; 33(5):277-83. PubMed ID: 7949630
[TBL] [Abstract][Full Text] [Related]
12. De novo revertant fiber formation and therapy testing in a 3D culture model of Duchenne muscular dystrophy skeletal muscle.
Ebrahimi M; Lad H; Fusto A; Tiper Y; Datye A; Nguyen CT; Jacques E; Moyle LA; Nguyen T; Musgrave B; Chávez-Madero C; Bigot A; Chen C; Turner S; Stewart BA; Pegoraro E; Vitiello L; Gilbert PM
Acta Biomater; 2021 Sep; 132():227-244. PubMed ID: 34048976
[TBL] [Abstract][Full Text] [Related]
13. Alternative dystrophin gene transcripts in golden retriever muscular dystrophy.
Schatzberg SJ; Anderson LV; Wilton SD; Kornegay JN; Mann CJ; Solomon GG; Sharp NJ
Muscle Nerve; 1998 Aug; 21(8):991-8. PubMed ID: 9655116
[TBL] [Abstract][Full Text] [Related]
14. Dystrophin expression in Duchenne patients with "in-frame" gene deletions.
Nicholson LV; Bushby KM; Johnson MA; Gardner-Medwin D; Ginjaar IB
Neuropediatrics; 1993 Apr; 24(2):93-7. PubMed ID: 8327067
[TBL] [Abstract][Full Text] [Related]
15. Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy.
Arahata K; Beggs AH; Honda H; Ito S; Ishiura S; Tsukahara T; Ishiguro T; Eguchi C; Orimo S; Arikawa E
J Neurol Sci; 1991 Feb; 101(2):148-56. PubMed ID: 2033400
[TBL] [Abstract][Full Text] [Related]
16. Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells.
van Deutekom JC; Bremmer-Bout M; Janson AA; Ginjaar IB; Baas F; den Dunnen JT; van Ommen GJ
Hum Mol Genet; 2001 Jul; 10(15):1547-54. PubMed ID: 11468272
[TBL] [Abstract][Full Text] [Related]
17. Sarcolemmal expression of dystrophin C-terminus but reduced expression of 6q-dystrophin-related protein in two DMD patients with large deletions of the dystrophin gene.
Bittner RE; Shorny S; Ferlings R; Sperl W; Kress W; Müller CR; Cremer M; Léger JJ; Voit T
Neuromuscul Disord; 1995 Mar; 5(2):81-92. PubMed ID: 7767097
[TBL] [Abstract][Full Text] [Related]
18. Dystrophin expression in a Duchenne muscular dystrophy patient with a frame shift deletion.
Prior TW; Bartolo C; Papp AC; Snyder PJ; Sedra MS; Burghes AH; Kissel JT; Luquette MH; Tsao CY; Mendell JR
Neurology; 1997 Feb; 48(2):486-8. PubMed ID: 9040743
[TBL] [Abstract][Full Text] [Related]
19. Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy.
Aartsma-Rus A; Janson AA; van Ommen GJ; van Deutekom JC
BMC Med Genet; 2007 Jul; 8():43. PubMed ID: 17612397
[TBL] [Abstract][Full Text] [Related]
20. Analysis of a dystrophin gene deletion by amplification of mRNA isolated from DMD myotubes cultured in vitro.
Ehrenpreis J; Hillers M; Junkes B; Pfordt M; Schwinger E; Vosberg HP
Genomics; 1991 Jul; 10(3):551-7. PubMed ID: 1889805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
